Cytosorbents Corporation

NASDAQ: CTSO · Real-Time Price · USD
1.15
0.01 (0.88%)
At close: Aug 15, 2025, 12:07 PM

Cytosorbents Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-20.72M -28.51M -32.81M -24.56M
Depreciation & Amortization
1.75M 2.03M 1.13M 1.13M
Stock-Based Compensation
3.76M 3.7M 3.8M 6.2M
Other Working Capital
-1.35M 1.1M 30.49K 145.06K
Other Non-Cash Items
5.16M -1.24M 3.21M 2.58M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-4.38M 2.36M -3.56M 641.9K
Operating Cash Flow
-14.43M -21.66M -28.23M -14.01M
Capital Expenditures
-284.34K -936.24K -6.46M -4.28M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-385.09K -398.12K n/a -640.01K
Investing Cash Flow
-669.43K -936.24K -6.46M -4.28M
Debt Repayment
10M n/a 5M n/a
Common Stock Repurchased
n/a n/a n/a -90K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-847.95K 218.28K n/a 805.2K
Financial Cash Flow
9.33M 14.47M 4.96M 715.2K
Net Cash Flow
-5.85M -8.22M -29.99M -17.6M
Free Cash Flow
-14.71M -22.59M -34.69M -18.29M